Press Releases

GlobeNewswire, Inc.

NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study NEO-CYT is a Phase 1b...

GlobeNewswire, Inc.

Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Informatics Market Size, Trends and Insights By Type (Electronic Health Records, Clinical Trial Management System,...

GlobeNewswire, Inc.

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- TMF Group, a leading provider of compliance and administrative services, today launches the 13th edition of the Global Business Complexity Index (GBCI), which shows that operating across borders is becoming...

GlobeNewswire, Inc.

Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Wearable Health Silicone Elastomers Market Size, Trends and Insights By Type (High Consistency Rubber, Liquid Silicone Rubber), By...

GlobeNewswire, Inc.

Austin, TX, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Flexible Endoscope Market Size, Trends and Insights By Product (Bronchoscopes, Laparoscopes, Otoscopes, Laryngoscopes, Cystoscopes,...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC...

EIN Presswire

IMARC Group's Latest Research Reveals a CAGR of 3.78% from 2026–2034, with Pearl Millet and Infant Food Segments Leading Expansion SHERIDAN, WY, UNITED STATES, May 11, 2026 /⁨EINPresswire.com⁩/ -- The global millet market size reached USD 14.0...

GlobeNewswire, Inc.

Origin, price and seasonality: the three-tier hierarchy emerging from the survey by the Research Department.

EIN Presswire

LogicalDOC Srl is proud to be a winner of the Top Performer award from SourceForge, the world’s largest software reviews and comparison website.

GlobeNewswire, Inc.

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session Company to host investor conference call and webcast during EHA 2026 on Saturday, June 13, at 9:00 a.m. ET (3:00...

EIN Presswire

FDA premarket rejections have surged since the February 2026 cybersecurity guidance.

GlobeNewswire, Inc.

Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis(3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%) EBITDA(1) of € 283.6 million, +5.0%, margin on net...

EIN Presswire

Russo’s New York Pizzeria announces nationwide franchise opportunities for qualified investors seeking to join a proven Italian dining brand.

GlobeNewswire, Inc.

Debra Hussain brings over 25 years of deep expertise in implementing commercial excellence and driving the launch of products and portfolio growth spanning multiple therapeutic areas Chiesi USA continues to invest in its US CARE business unit,...

GlobeNewswire, Inc.

- Phase 3 CALIBRATE primary results were presented in an oral presentation at the 2026 ECE, demonstrating the rapid and durable benefit of encaleret across key clinical parameters in ADH1 - All pre-specified primary and key secondary efficacy...

DVIDS - Georgia

AVIANO AIR BASE, Italy – On April 20th, U.S. Air Force Tech. Sgt. Joseph Dixon, 31st Force Support Squadron education center civilian training manager, was driving his daughter to fencing practice when he suddenly encountered the immediate,...

GlobeNewswire, Inc.

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 62% versus first quarter of 2025 to approximately $597 million CARVYKTI® now available across 18 global markets, following recent launches in Italy, Poland, the Czech...

GlobeNewswire, Inc.

TAMPA, Fla. and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the grant of...

GlobeNewswire, Inc.

NEW YORK, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Coffee Beauty Products Market By Product Type (Hair Care Products, Skincare Products, Body Care Products, Color Cosmetics, and...

GlobeNewswire, Inc.

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas Institute of the University of Verona The study is the first Alpha DaRT pancreatic cancer protocol worldwide...